While TNF-α inhibitors are widely used to treat multiple inflammatory conditions, including inflammatory bowel disease and inflammatory spondyloarthropathy, there is a growing body of literature documenting paradoxical reactions, such as drug-induced sarcoidosis. The gene discussed is TNF; the disease is sarcoidosis.